Literature DB >> 11857495

Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.

Vuokko L Kinnula1, S Lehtonen, R Sormunen, R Kaarteenaho-Wiik, S W Kang, S G Rhee, Y Soini.   

Abstract

Peroxiredoxins (Prxs) are a recently characterized group of thiol-containing proteins with efficient antioxidant capacity, capable of consuming hydrogen peroxide in living cells. Altogether six distinct Prxs have been characterized in mammalian tissues. Their expression was investigated in histological samples of mesothelioma and in cell lines established from the tumours of mesothelioma patients. Four cases with histopathologically healthy pleura from non-smokers were used as controls. Healthy pleural mesothelium was negative or very weakly positive for all Prxs. In mesothelioma, the most prominent reactivity was observed with Prxs I, II, V, and VI. Prx I was highly or moderately expressed in 25/36 cases, the corresponding figures for Prxs II-VI being 27/36 (Prx II), 13/36 (Prx III), 2/36 (Prx IV), 24/36 (Prx V), and 30/36 (Prx VI). Positive staining was observed both in the cytosolic and the nuclear compartment, with the exception of Prx III, which showed no nuclear reactivity. The staining pattern of Prxs III and V was granular. Immunoelectron microscopic localization of Prxs was in accordance with the immunohistochemical findings, showing diffuse cytoplasmic localization for Prxs I, II, IV, and VI and distinct mitochondrial labelling for Prxs III and V. There was no significant association between the extent of staining and different Prxs. It appeared that Prxs may not have prognostic significance, but being prominently expressed in most mesotheliomas these proteins, at least in theory, may play a role in the primary drug resistance of this disease. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857495     DOI: 10.1002/path.1042

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  68 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

2.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

3.  Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Authors:  Chul-Kee Park; Jin Hyun Kim; Min Jeong Moon; Ji Hye Jung; Su-Young Lim; Sung-Hye Park; Jong-Hoon Kim; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho; Sun Ha Paek
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-26       Impact factor: 4.553

4.  HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation.

Authors:  R B Parmigiani; W S Xu; G Venta-Perez; H Erdjument-Bromage; M Yaneva; P Tempst; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

5.  Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.

Authors:  Kirsi Vuorinen; Steffen Ohlmeier; Outi Leppäranta; Kaisa Salmenkivi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  J Histochem Cytochem       Date:  2008-07-07       Impact factor: 2.479

Review 6.  Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.

Authors:  Jan F Stevens; Johana S Revel; Claudia S Maier
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

7.  Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Authors:  Jung Mi Byun; Su Sun Kim; Ki Tae Kim; Mi Seon Kang; Dae Hoon Jeong; Dae Sim Lee; Eun Jung Jung; Young Nam Kim; Jin Han; In Sung Song; Kyoun Bok Lee; Moon Su Sung
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

8.  Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.

Authors:  Jie Zhou; Weiwen Shen; Xiaojing He; Jing Qian; Shiyuan Liu; Guanzhen Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.

Authors:  Sally Järvelä; Immo Rantala; Alejandra Rodriguez; Heini Kallio; Seppo Parkkila; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

10.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.